Obesity:
Indications for: Diethylpropion sustained-release tabs
Short-term adjunct in management of exogenous obesity.
Adult Dosage:
25mg 3 times daily 1 hr before meals and in midevening for night hunger or one 75mg sustained-release tab daily in midmorning.
Children Dosage:
Not recommended.
Diethylpropion sustained-release tabs Contraindications:
Arteriosclerosis. Hypertension. Hyperthyroidism. Glaucoma. Agitation. Drug or alcohol abuse. During or within 14 days of MAOIs.
Diethylpropion sustained-release tabs Warnings/Precautions:
Discontinue after a few weeks as tolerance to anorectic effect occurs. Epilepsy. Cardiovascular disease. Arrhythmias. Diabetes. Prescribe limited supply to prevent overdose. Pregnancy (Cat.B). Nursing mothers.
See Also:
Diethylpropion sustained-release tabs Classification:
Sympathomimetic.
Diethylpropion sustained-release tabs Interactions:
Hypertensive crisis with MAOIs. Blocks guanethidine. Adverse reaction with alcohol. Arrhythmias may occur with general anesthetics. Antagonized by phenothiazines.
Adverse Reactions:
Abuse potential, impairment in hazardous activities, arrhythmias, hypertension, CNS overstimulation, psychosis, dry mouth, GI disturbances, urticaria, impotence, seizures, blood dyscrasias, dyspnea, hair loss, dysuria.
Note:
Formerly known under the brand names Tenuate, Tepanil (tabs); Tenuate Dospan, Tepanil Ten-tab (SR tabs).
How Supplied:
Contact supplier.
